Does duration of untreated psychosis bias study samples of first-episode psychosis?

Acta Psychiatrica Scandinavica
S FriisT H McGlashan

Abstract

While findings are contradictory, many studies report that long Duration of Untreated Psychosis (DUP) correlates with poorer outcome in first episode psychosis. In an outcome study of first-episode psychosis, we compared the patients who refused to participate in a follow-along with those who consented to estimate the importance of this factor in sample recruitment bias. Our questions were: (i) What is the percentage of refusers? (ii) Are there systematic differences between refusers and consenters on DUP and/or other admission variables? (iii) What is the risk of refusal for different values of DUP? In an unselected group of consecutively admitted patients we compared follow-along refusers and consenters on the following admission variables: sex, age, diagnostic group, substance abuse, being in-patient, coming from an early detection site and DUP. We conducted a logistic regression analysis with refusal as the outcome variable. Ninety-three of 397 patients (23%) were refusers. In univariate analyses the only significant difference was found for DUP. The median DUP for consenters was 10 weeks and for refusers 32 weeks. DUP remained significant when all independent variables were controlled for. DUP was significantly related to ...Continue Reading

References

Sep 1, 1992·The American Journal of Psychiatry·A D LoebelS R Szymanski
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Feb 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·E C JohnstoneJ F MacMillan
Jan 1, 1996·Schizophrenia Bulletin·P D McGorryH J Jackson
Feb 1, 1997·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·L Davidson, T H McGlashan
Oct 30, 1998·Journal of Psychiatric Research·R J Wyatt, I D Henter
Feb 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·S BrowneE O'Callaghan
Aug 22, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·L de HaanJ Wolthaus
Oct 21, 2000·The British Journal of Psychiatry : the Journal of Mental Science·T R BarnesE M Joyce
Nov 4, 2000·The American Journal of Psychiatry·D FannonT Sharma
Dec 5, 2000·The British Journal of Psychiatry : the Journal of Mental Science·R J DrakeS W Lewis
May 31, 2001·Acta Psychiatrica Scandinavica·H Verdoux
May 31, 2001·Acta Psychiatrica Scandinavica·T K LarsenP Vaglum
Aug 2, 2001·Schizophrenia Research·J O JohannessenP Vaglum
Aug 2, 2001·Schizophrenia Research·R J Wyatt, I Henter
Oct 3, 2001·The British Journal of Psychiatry : the Journal of Mental Science·R M NormanA K Malla
Apr 13, 2002·Schizophrenia Research·G P AmmingerP D McGorry
Apr 13, 2002·Schizophrenia Research·Ashok K MallaJatinder Takhar
Sep 13, 2002·Acta Psychiatrica Scandinavica·Patrick D McGorry
Nov 27, 2002·European Archives of Psychiatry and Clinical Neuroscience·Ronald BottlenderHans-Jürgen Möller

❮ Previous
Next ❯

Citations

Apr 11, 2006·Social Psychiatry and Psychiatric Epidemiology·Michael T ComptonNadine J Kaslow
Dec 7, 2007·Social Psychiatry and Psychiatric Epidemiology·Matthew M LargeRobert Hayes
Jun 25, 2008·Social Psychiatry and Psychiatric Epidemiology·Anne KøsterBent Rosenbaum
Sep 27, 2007·European Child & Adolescent Psychiatry·Nora S VyasSophia Frangou
Feb 4, 2009·Psychological Medicine·C WhiteS Lewis
Jan 21, 2009·The Australian and New Zealand Journal of Psychiatry·Jo RobinsonMartin Lambert
Sep 12, 2006·European Child & Adolescent Psychiatry·Andor E SimonDaniel Umbricht
Jun 8, 2010·Pharmacy World & Science : PWS·Jeff HarrisonAmanda J Wheeler
Jun 29, 2007·Social Psychiatry and Psychiatric Epidemiology·Sharon R FoleyEadbhard O'Callaghan
Mar 8, 2016·Schizophrenia Research·Erlend Strand GardsjordJan Ivar Røssberg
Dec 2, 2009·Schizophrenia Research·Ann FaerdenIngrid Melle
Nov 1, 2008·Early Intervention in Psychiatry·Matthew LargeAnthony Harris
Nov 1, 2007·Early Intervention in Psychiatry·Jean Addington
Mar 1, 2008·International Journal of Mental Health Nursing·Simone I Reed
Apr 28, 2006·Acta Psychiatrica Scandinavica·A WunderinkD Wiersma
Sep 15, 2006·Schizophrenia Research·Tor K LarsenThomas H McGlashan
Jul 26, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Benno Graf SchimmelmannMartin Lambert
Jul 15, 2015·Social Psychiatry and Psychiatric Epidemiology·Frauke Schultze-LutterJoachim Klosterkötter
Jun 22, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·I MelleT McGlashan
Apr 30, 2016·Early Intervention in Psychiatry·Nadja P MaricTijana Mirjanic
Sep 8, 2012·The Australian and New Zealand Journal of Psychiatry·Svein FriisThomas McGlashan
Jan 1, 2006·International Journal of Psychiatry in Clinical Practice·Rolf Wynn
Feb 18, 2012·The Cochrane Database of Systematic Reviews·Adib Essali, Ghassan Ali
Jun 17, 2011·The Cochrane Database of Systematic Reviews·John BolaHaluk Soydan
Nov 30, 2018·Social Psychiatry and Psychiatric Epidemiology·Emily KlineLarry J Seidman
Aug 2, 2005·The British Journal of Psychiatry. Supplement·Svein FriisThomas H McGlashan
Feb 16, 2017·Schizophrenia Bulletin·Melissa A WeibellSvein Friis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.